Bio-Rad Laboratories（纽约证券交易所代码：BIO）报告季度每股收益为 $2.90，高于分析师一致预期的 $2.86，增幅为 1.4%。 与去年同期的每股收益 $3.10 相比，下降了 6.45%。公司报告季度销售额为 $6.675亿，低于分析师一致预期的 $6.793亿，减少了 1.74%。 与去年同期的销售额 $6.8118亿 相比，减少了 2.01%。

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.90 per share which beat the analyst consensus estimate of $2.86 by 1.4 percent. This is a 6.45 percent decrease over earnings of $3.10 per share from the same period last year. The company reported quarterly sales of $667.50 million which missed the analyst consensus estimate of $679.30 million by 1.74 percent. This is a 2.01 percent decrease over sales of $681.18 million the same period last year.